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Abstract 
 
This study determined E. coli resistance to commonly used antibiotics together with their virulence 
properties in Ile-Ife, Nigeria. A total of 137 E. coli isolates from cases of urinary tract infection were tested for their 
sensitivity to commonly used antibiotics and possession of virulence factors using standard methods. Their ability 
to transfer resistance was also determined. The isolates demonstrated a high and widespread resistance (51.1 % 
to 94.3 %) to all the antibiotics used except Nitrofurantoin (7.3 %). A total of 50 (36.5 %) of the isolates were 
resistant to 10 of the eleven antibiotics employed. Sixty three per cent (63 %) of the 107 trimethoprim resistant E. 
coli transferred their resistances while amoxicillin, gentamycin, augmentin, tetracycline and erythromycin were co-
transferred with trimethoprim. Fifty one (37.2 %) of these multi-resistant isolates possessed one or more virulent 
factors. The study concluded that urinary tract infection due to E. coli in Ile-Ife may be difficult to treat empirically 
except with nitrofurantoin, due to high resistance to commonly used antibiotics. It is imperative that culture and 
susceptibility tests be carried out on infecting pathogen prior to treatment, in order to avoid treatment failure and 
reduce selective pressure that could result in the spread of uropathogenic E. coli in the environment. 
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Introduction 
 
Urinary tract infections are among the most common bacterial infections in humans and Escherichia coli 
is by far the most commonly recovered bacterial pathogen from both hospital and community patients with this 
infection (Hryniewcz et. al., 2001, Dasgupta et. al., 2005). The E. coli that cause urinary tract infection are not all 
the strains from the intestinal tract but a subgroup selected by factors enhancing extra intestinal survival. Such 
factors include motility by the aid of flagella, structural features such as fimbriae or pili and chemical adhesion 
(Emody et. al., 2003). The type-1 pili also known to be the most widely distributed among uropathogenic E. coli 
binds to mannose containing glycoprotein receptors on facet cells lining the bladder or vaginal epithelial cells and 
are known to be associated with increased severity of   UTI (Venegas et. al., 1995; Todar, 2008). An array of 
other virulence factors has also been identified (Emody et. al., 2003) which confer on some faecal E. coli the 
ability to colonise the vaginal mucosa and cause symptomatic urinary diseases. This group of E. coli is known 
collectively as uropathogenic E. coli (UPEC) clones (Orskov and Orskov, 1985). 
There is the need to eliminate these organisms in order to avoid treatment failure which could lead to 
proliferation of virulent E. coli and consequent morbidity. In settings where resistance to cotrimoxazole 
(trimethoprim/sulphamethaxole) in E. coli is less than 20%, a short course of cotrimoxazole is the recommended 
empirical treatment for acute uncomplicated cystitis (Lescure et. al., 2001). However the ability of E. coli to cause 
urinary tract infections is on the increase, while the ease of treating these infections due to multidrug antibiotic 
resistance to first line antibiotics such as cotrimoxazole, ampicillin and nitrofuranton is becoming increasingly 
elusive. Of greater concern is the recent increase in resistance to fluoroquinolones such as ciprofloxacin and 
levofloxacin (Hooton, 2003; Karlowsky et. al., 2006).  
The increasing ability of E. coli to cause urinary tract infections and the difficulty encountered in treating 
these infections due to multidrug antibiotic resistance necessitates updating the knowledge of their drug 
resistance in a given environment. This is particularly necessary in a suburban community like Ile-Ife of Southwest 
Nigeria where all kinds of antibiotics are available across the counter with or without prescription (Okeke and 
Lamikanra, 2001). Hence, the objective of this work was to study and determine the antibiotic susceptibility and 
resistance of pathogenic E. coli isolated from cases of urinary tract infection in Ile-Ife, Nigeria. This is with a view 
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to selecting the right antibiotics for effective treatment of urinary tract infections caused by Escherichia coli. The 
study will also demonstrate the virulence factors that contribute to their persistence in UTI patients.  
 
 
Materials and Methods 
Isolation of Escherichia coli  
 
 A total of 137 strains of E. coli were isolated from urinary tract infections at two tertiary care hospitals in 
Ile-Ife between May 2003 and December 2005. Clean voided midstream and suprapubic aspirates urine samples 
were collected daily with the assistance of hospital medical personnel into sterile universal bottles from both in-
patients and out-patients suspected to have a urinary tract infection. Culture was done by the calibrated loop 
technique delivering approximately 0.01 ml. of urine, and cultured on MacConkey agar (Oxoid, England) or 
Cystine-Lactose Electrolyte-Deficient (CLED) agar medium to obtain isolated colonies. Only E.coli colonies 
showing a significant growth of 105 colony forming units per milliliter or more of urine samples after incubation at 
37 oC for 24 h were considered in this study. 
This was based on colony morphology and cultural characteristics on MacConkey agar and EMB agar. 
The presence or absence of growth, colour, whether they were mucoid or non-mucoid and consistency of 
colonies produced by each isolate on the media were observed and recorded. The isolates were further identified 
using standard microbiological methods (Barrow and Feltham, 1993). All Gram negative isolates that showed 
positive results for motility, lactose fermentation, indole production, and inability to utilize citrate as a sole carbon 
source were defined as E. coli and stored in Nutrient Agar. 
 
Antimicrobial susceptibility testing 
 
Isolates were tested for antimicrobial susceptibility by using the standard agar disc  diffusion method 
(NCCLS,1993) on Tryptone soy agar surface already seeded with the organism using cotton tipped applicator 
(Sterilin Ltd. Middlesex, U.K.).  The multidisc used (AB Biodisk) contained the following antibiotics arranged 
equidistant to each other – amoxicillin, 250 µg; trimethoprian/sulphamethaxole, 25 µg; nitrofurantoin, 300 µg; 
gentamycin, 10 µg; nalidixic acid, 30 µg; ofloxacin, 30 µg; augmentin, 30 µg; tetracycline, 30 µg; erythromycin, 15 
µg; norfloxacin, 10 µg; and ciprofloxacin, 10 µg; The plates were refrigerated at 4 oC for 30 minutes to ensure 
adequate diffusion of the antibiotics before incubation at 37 oC for 18 h. The diameters of inhibition zones were 
measured in millimeter, and interpreted in accordance with the manufacturer’s recommendations (AB Biodisk; 
PDM Interpretative Chart). 
    
Minimum Inhibitory Concentration (MIC) of Trimethoprim 
 
The MIC for all trimethoprim resistant E. coli isolates was determined by the agar dilution method 
(NCCLS,1993). A 1:1000 dilution of overnight culture of each isolate was prepared in sterile distilled water and the 
resultant suspension was applied to the surface of dried iso sensitest agar containing doubling dilution (1024 – 
4mg/l) of trimethoprim lactate (Welcome Foundation, Sweden) in duplicate plates, with a multipoint inoculators. 
The concentration of trimethoprim inhibiting growth after 24 h incubation at 37 oC was taken as the MIC. 
 
In-vitro Transconjugation experiment 
 
Mating experiment were conducted for all Trimethoprim resistant isolates on  Triptone agar plate with the 
trimethoprim sensitive, nalidixic acid resistant E. coli K-12 C600 as recipient. Transconjugants were harvested on 
Tryptone Soy Agar plates containing 10 mg/L trimethoprim and 40 mg/L nalidixic acid (Sigma Chemical Company, 
St. Louis, USA). All transconjugants were screened for threonine marker of E. coli K-12 C600 and for resistance 
to antibiotics to which the donor organisms were resistant. 
 
Detection of virulence factors 
Capsule formation 
 
This was done by the combined positive and negative staining method described by Okeke and 
Lamikanra, [1995].  The organisms appeared red against a blue background, while the presence of capsule was 
observed as a clear zone around each bacterium. 
 
Haemolysin 
 
All the E. coli isolates were screened for haemolytic activity on nutrient agar plates containing 7 % 
washed human erythrocytes.  A distinct colony of the organism was streaked and stabbed on the nutrient agar 
plate containing 7 % washed erythrocyte and incubated at 37 °C for 18 h. The erythrocytes were then observed 
for lyses, as indicated by the blood free zone surrounding the colony stab. 
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Colicin production 
 
This was carried out using the agar overlay method described by Barth et. al. (1978), E. coli K-12 C600 
was used as indicator organism. Plates were observed for the formation of inhibition zones around the test 
organism stabs. 
 
Haemaglutination 
 
Haemaglutination was detected by clumping of erythrocytes by fimbriae of bacteria in the presence of D-
mannose using the method described by Evans et al. (1979). Washed erythrocytes were recovered from freshly 
collected blood from human type ‘A’ donor. Strains were classified as showing instantaneous haemaglutination 
(4+); almost instantaneous (within 60 s at room temperature (3+); within 5 min on ice (2+); within 30 min on ice 
(1+); or no haemaglutination (0). 
 
 
Results 
 
A total of 137 E. coli strains were isolated from the urine samples that met the inclusion criteria of 105 
colony forming units per millilitre of urine. Those samples without growth or with growth less than 105 cfu/ml of 
urine were excluded from this study. Eighty one isolates, representing 59.1% of the total isolates were recovered 
from female patients, while 56 (40.9%) were isolated from male patients. 
  
Antibiotic susceptibility studies of E. coli 
 
The results showed widespread resistance (51.1 - 91.2 %) of the isolates to all the antibiotics, except 
nitrofurantoin with resistance rate of 7.3 % (Figure 1). Among the fluoroquinolones, ofloxacin showed the least 
resistance (51.1 %), followed by Ciprofloxacin (65.7 %) and Norfloxacin (86.9 %). The result also showed (Figure 
2) that the E. coli isolates were multiply-resistant with the highest percentage of multiresistant isolates skewed 
toward the highest number of antibiotics. Up to 50 (36.5%) strains were resistant to 10 out of the 11 antibiotics 
employed. A total number of 20 (14.6 %), 18 (14.14 %) and 13 (9.5 %) isolates were resistant to 7, 8 and 9 
antibiotics respectively, while 8 (5.8 %) of the isolates were resistant to all the antibiotics employed. 
                                          
Transfer of resistance 
 
Out of the 107 trimethoprim resistant E. coli tested, 63.6 % were able to transfer their resistant traits to 
plasmidless E. coli K12 C600. A high percentage of these isolates that transferred their resistances also fall within 
the highly resistant strains, i.e., those having their MIC above 1000 mg/ml. of trimethoprim. The result also 
showed that five of the antibiotics: amoxicillin (88.9 %), gentamycin (20 %), augmentin (67.5 %), tetracycline (72.2 
%) and erythromycin (57.1 %) were co-transferred with trimethoprim. 
  
 
Figure 1: Percentage resistance of E. coli to different antibiotics. 
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Figure 2: Percentage multiresistance of E. coli isolates to the antibiotics. 
 
Occurrence of E. coli with virulence markers 
 
 The percentage occurrence of the different virulence markers among the E. coli isolates (Table 1) 
showed that fifty one isolates representing 37.2 % were capsulated. A total of 19 (13.9 %) strains showed 
mannose resistant haemagglutination, while 13 (9.5 %) produced the exotoxin colicin. Ten (7.3 %) isolates were 
haemolytic. The four different markers also occurred both singly and in different combinations among the isolates 
and were all multi-resistant (Table 2).         
 
Table 1:  Number of Isolates with different Virulence markers 
 
Number (%) of isolates     Virulence property 
51 (37.2)     Capsulated 
  
19(13.9)     Mannose resistant haemaglutination 
  
13(9.5)     Colicin 
  
10(7.3)     Haemolysin 
  
 
 
 
Discussion 
 
  The results of this work showed a higher percentage of isolates from female patients (59.1 %) than 
males (40.9 %). This is consistent with previous findings that UTI is more common in females than their male 
counterparts (Foxman et. al., 2000; Aiyegoro et. al., 2007; Omoregie et. al., 2008). There was a wide range of 
resistance of the E. coli isolates [Figure 1] to all the commonly used antibiotics in this environment, namely, 
amoxicillin, gentamicin, cotrimoxazole, augmentin, ciprofloxacin, norfloxacin, streptomycin and nalidixic acid. The 
result also showed a higher level of resistance of E. coli than were reported by previous workers (Lamikanra and 
Ndep, 1989). The result is however in agreement with the report that antibiotic resistance in E. coli isolates from 
urinary tract infection is on the increase (Kurutepe et. al., 2005). 
The high level of resistance to the fluoroquinolones limits the options for effective treatment of urinary 
tract infection caused by E. coli in this environment. This is because fluoroquinolone antibiotics were considered 
to be critical antibiotics due to their very high effectiveness against pathogens that are resistant to other 
antibiotics. It is evident from this study that fluoroquinolones can no longer be employed as alternative to the less 
effective trimethoprim/sulphamethaxole (Cotrimoxazole) for empirical treatment of UTI caused by E. coli within 
this study area. The only exception among the tested antibiotics is nitrofurantoin, to which the organisms exhibited 
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a resistance as low as 7.3 % [Figure 1]. The high sensitivity shown to this antibiotic is consistent with the result of 
other workers (Gupta et. al., 2001; Karlosky et. al., 2002), in other parts of the world. The reason while 
nitrofurantoin continues to show high sensitivity is not yet understood, only that this synthetic antibacterial does 
not belong to the group of any of the other antibiotics. It may also be related to the fact that the drug is not as 
commonly used as the other anti-infective agents such that, with less consistent drug pressure, the microbial 
sensitivity is sustained. 
 
Table 2: Numbers of uropathogenic E. coli isolates with one or more virulence  markers and their resistance level. 
 
Virulence Markers Number of isolates Resistant to: 
   
One marker   
COL 8 2-10 antibiotics 
HL 2 4-10 antibiotics 
CAP 22 2-11 antibiotics 
MRHA 10 2-11 antibiotics 
Total 42  
   
Two Markers   
COL+HL 2 9-10 antibiotics 
HL+CAP 3 9-10 antibiotics 
HL+MRHA 0 - 
CAP+MRHA 7 6-11 antibiotics 
COL+CAP 3 7-10 antibiotics 
Total 17  
   
Three Markers   
HL+CAP+MRHA 1 7 antibiotics 
Total 1  
 
Key: COL = Colicin formation, CAP = Capsule, MRHA = Mannose resistant   
        haemaglutination, HL = Haemolysin production. 
 
 
It is evident from the result of this work that majority of the E. coli isolates are highly and multiply-resistant.  The 
reason for this high level of resistance could be due to the fact that ingestion of antibiotics is known to provide 
selective pressure ultimately leading to a higher prevalence of resistant bacteria (Okeke et. al., 2000). In most 
towns and cities in Nigeria, these antibiotics are readily made available over the counter without prescriptions. 
The indiscriminate use and misuse of antibiotics and the consumption of substandard antibiotics as earlier 
reported (Okeke and Lamikanra, 1995) might have over the years contributed to the high rate of antibiotic 
resistance recorded in this study. 
About 63 % of the trimethoprim resistant isolates were able to transfer their resistance into a plasmidless 
E. coli strain.  It is to be noted also that most of these trimethoprim resistant isolates were able to grow in the 
presence of more than 1000 mg/l of trimethoprim, indicative of high level of resistance. Co-transfer of resistance 
of trimethoprim and amoxicillin was predominant and this was followed by co-transfer with tetracycline, augmentin 
erythromycin and gentamycin respectively. Adeleye (1992) reported that while genes encoding multiple antibiotic 
resistances are not always transferable they are often located on easily mobilised plasmids.  Therefore, the 
widespread antibiotic resistance encountered in these isolates can however, be due not only to the indiscriminate 
use of drugs in this community, but also to the early transferability of plasmids. 
Identification and evaluation of virulence factors are necessary for a more complete understanding of the 
pathogenesis of E. coli UTI and may in turn lead to the logical development of new strategies for the prevention 
and treatment of UTI and other infections caused by the pathogens.  In this study, 37.2 % strains were 
encapsulated (Table 1) and phenotypic characterisation reveals that eight of these encapsulated strains were 
mucoid within 18-24 h. Capsules are known to confer serum and phagocyte resistance to some E. coli strains 
(Russo et. al., 1996; Warren, 1997).  
Colicin is a narrow spectrum bactericidal macro molecule which is produced by some strains of E. coli.  
Each colicin plasmid is known to confer immunity to the particular colicin which it encodes (Cariksi and Cosar, 
2001). Thirteen (9.5%) of the 137 E. coli strains in this study produced colicin. Although there have been a dearth 
of information on colicin production by uropathogenic E. coli in this locality, the figure recorded in this study is 
lower than 25.5 %, 26.2 % and 36.3 %   reported in other parts of the world (Cariksi and Cosar, 2001; Davies et. 
al., 1981; McGeachie, 1965). This difference may be due to reported differences in the characteristics of strains 
found in different countries during various periods (Djonne, 1985). Okeke et. al. (2000) reported a high rate of 
colicinogenicity among enteroaggregative E. coli (EAEC) strains isolated from children in Southwest Nigeria and 
suggested (Okeke et. al., 2000) that this may partially explain the documented association of EAEC with 
persistent diarrhoea (Bhan et. al., 1989, Baqui et. al., 1992) because abundant adherence and elimination of 
competing commensals may favour prolonged colonisation and treatment failure. This condition may also be 
applicable in urinary tract infection.                                                                                                     
Olorunmola et al., Afr. J. Infect. Dis. (2013) 7(1): 1 – 7 
http://dx.doi.org/10.4314/ajid.v7i1.1 
 
6
 
Agglutination of red blood cells commonly known as haemagglutination is mediated by finbriae (Dugguid 
et. al., 1979), and is proportionate to the ability to adhere to uroepithelial cells. In mannose resistant 
haemagglutination (MRHA) the P- blood group antigen acts as a receptor for these organisms and they have 
improved binding to uroepithelial cells (Emody et. al., 2003).  In this study 19 (13.9%) of the isolates produced 
mannose resistant haemagglutination (Table 1).  This value is lower than the 30.9 % reported in India (Raksha et. 
al., 2003). 
Also, a total of ten (7.3%) of the isolates produced the toxin, haemolysin.  The cytolytic protein toxin 
secreted by most haemolytic E. coli isolates is known as alpha-haemolysin.  Three (30%) of the ten haemolysin 
producing E. coli were α-haemolytic. Cytotoxic necrotising factor (CNF-1) production increases the capacity of 
UPEC strains to resist killing by neutrophils, which in turn permits these bacteria to gain access to deeper tissue 
and persist better in the lower urinary tract (Rippere-Lampe et. al., 2001) 
The results also showed that sixty (53.2 %) of the E. coli isolates (Table 2) had one or more virulence 
markers.  It has been reported (Raksha et. al., 2003) that haemolysin production, presence of capsule and 
capacity to cause MRHA emerged as important virulence factors in E. coli UTI. P-fimbriae which often confers on 
E. coli the capacity to cause MRHA is known to induce higher interleukin (IL) -8, IL-6 and neutrophil responses in 
the urinary tract (Wullt et. al., 2001).  In the same way, α-haemolysin, also known as cytotoxic necrotising factor 
triggers inflammatory response leading to secretion of IL-6 and chemotoxins which set the pace for pathogenesis 
of renal disease. 
The result of this study revealed the occurrence of some virulence factors namely, haemagglutin colicin 
haemolysin and capsule, which confer pathogenicity on the predominant E. coli isolates from urinary tract 
infections in this environment.  It is now evident that a considerable number of E. coli isolates from this study 
community which, apart from being highly and multiply antibiotic resistant, are well equipped to enter the urinary 
tract and cause symptomatic disease. 
It also showed that empirical treatment of E. coli UTI is no longer working in this environment. In order to 
avoid treatment failure, culture and susceptibility tests should be carried out on infecting pathogens before an 
antibiotic is selected for treatment.  This would discourage the indiscriminate use of antibiotics and reduce 
selective pressure that could result in the spread of virulent and resistant uropathogenic E. coli in the 
environment. 
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